• Press
  • Offices
  • Contact
  • Legal notice
  • LinkedIn
  • EN
    • DE
  • UPC
  • Firm
    • Main Focus
    • History
    • Guiding Principle
    • Code of Conduct
    • Awards and Rankings
  • Our Team
  • News & Knowledge
    • News
    • Events
    • UPC-Update
    • IP-Update
    • EmpCo Directive
    • Publications
    • Subscription B&B Bulletin
  • Our Practice
    • Legal Areas
    • Industries
  • Career
  • Menu Menu
FIND EXPERTS
  • UPC
  • Firm
  • News & Knowledge
    • News
    • Events
    • UPC-Update
    • IP-Update
    • EmpCo Directive
    • Publications
    • B&B Bulletin
  • FIND EXPERTS
  • Contact
  • Offices
  • Our Practice
  • Career
  • EN
    • DE
  • Legal Areas
  • Industries

Patent seminar, Bremen, April 11, 2018

26. March 2018/in News

A patent seminar will be held in Bremen on April 11, 2018 Experts will provide information on the following topics:

  • Patent lawyer Dr. Volker Scholz: The right claim: defining the object of invention
  • Patent lawyer Fritz Jetzek: Utility patents: useful protection
  • Patent lawyer Dr. Uwe Manasse: Separation of patent breach and invalidity procedures: judgement against despite uncertain legal validity?
  • Patent lawyer Dr. Matthias Philipp: Recognising patent breaches in practice
  • Patent lawyer Dr. Martin Erbacher: US patent applications: slightly different from the rest

Detailed information on the event location is available in the programme. Please register with Dr. Volker Scholz by reply card or email.

/wp-content/uploads/2022/04/boehmert_logo.svg 0 0 Petra Hettenkofer /wp-content/uploads/2022/04/boehmert_logo.svg Petra Hettenkofer2018-03-26 00:00:002018-03-26 00:00:00Patent seminar, Bremen, April 11, 2018

German Unfair Competition Act (UWG) regulates entries on member structure – Dr Rudolf Böckenholt explains the details in his recent GRUR-Prax article

22. March 2018/in News

In Edition 5/2018 (p. 134), Dr. Rudolf Böckenholt explains the decision of the Saarland Higher Regional Court which held that, in accordance with §8(3)(2) UWG, associations must set out their active legitimation regarding member structure without giving rise to an actual presumption from previous actions against third parties. 

The magazine GRUR-Prax can be accessed from the publisher. More details can be found at.

/wp-content/uploads/2022/04/boehmert_logo.svg 0 0 Petra Hettenkofer /wp-content/uploads/2022/04/boehmert_logo.svg Petra Hettenkofer2018-03-22 00:00:002018-03-22 00:00:00German Unfair Competition Act (UWG) regulates entries on member structure – Dr Rudolf Böckenholt explains the details in his recent GRUR-Prax article

BOEHMERT & BOEHMERT Partner at the #Karajan #MusicTech Conference on 23.03.2018 in Salzburg

21. March 2018/in News

The Eliette and Herbert von Karajan Institute acting in coordination with the Salzburg Easter Festival and the University Mozarteum Salzburg will hold a one-day conference on music and technology – the #Karajan #MusicTech Conference.

Prof. Dr. Christian Czychowski will take part in a panel discussion at the event together with Ferdinand von Strantz, CEO Highlight Event AG, and Matthias Röder, CEO Karajan Institute. Here, new forms of exploitation of classical music – in particular in connection with streaming – will be discussed.

More details on the event can be found at.

/wp-content/uploads/2022/04/boehmert_logo.svg 0 0 Petra Hettenkofer /wp-content/uploads/2022/04/boehmert_logo.svg Petra Hettenkofer2018-03-21 00:00:002018-03-21 00:00:00BOEHMERT & BOEHMERT Partner at the #Karajan #MusicTech Conference on 23.03.2018 in Salzburg

Need for action due to Changes to Official Fees at the EPO on April 1, 2018?

15. March 2018/in News

Abrogation of Reduction of Fees for Non-European International Search Authorities (ISAs)

In 2005, the European Patent Office (EPO) reduced the fee for the supplementary European search for a patent application under the Patent Cooperation Treaty (PCT) if the international search report was drawn up by the national patent offices of the US, Japan, Korea, China, Russia, or Australia.

The Administrative Council has now abrogated this decision, and hence a reduction of the fee for the supplementary European search no longer applies for these cases. In the future, the full fee for the supplementary European search in the amount of 1,300.00 EUR must be paid.

The changes enter into force on April 1, 2018 and are applicable for all PCT applications where the regional phase thereof is entered on April 1, 2018 or later. Thus, applicants of PCT applications in the international phase, for which an international search report was drawn up by one of the above-mentioned patent offices, should consider performing the steps necessary for entry of the regional phase at the EPO by March 31, 2018 at the latest in order to still benefit from the reduced search fee.

The fee reduction for the supplementary European search remains unchanged in cases where the international search report was drawn up by an office being part of the ’European Partnership’ (currently the national patent offices of Spain, Sweden, Finland, Austria, and Turkey, as well as the Nordic Patent Institute and the Visegrad-Patent Institute).

Fee Incentives for the Implementation of XML

The EPO desires to establish online filing using the character-coded format (XML) as the standard format for filings. In order to make this more attractive, the EPO will allow filings in DOCX, the character-coded format that most users use for their daily work. The EPO has announced that it will provide an electronic tool that, starting on April 1, 2018, will make it possible to file online both applications and later filed documents in DOCX. Furthermore, the application fee and the fee for grant are reduced for patent applications in character-coded format.

The application fee is reduced to 90.00 EUR if the European patent application is filed online in a character-coded format. Corresponding regulations are provided for the entry into the European phase based on an international application. If any of the required documents is not filed online in character-coded format the application fee is 120.00 EUR. For a filing of the application on paper the application fee is increased to 250.00 EUR.

The fee for grant is reduced to 835.00 EUR, if, starting from April 1, 2018, all changes and corrections of the application as well as the translation of the claims are filed online in character-coded format. In all other cases the fee for grant, including the publication fee, remains at 925.00 EUR. However, the Administrative Council has already decided to raise this fee to 1,025.00 EUR starting on April 1, 2019.

Additional reductions for the filing of documents online and in character-coded format are planned.

Coverage of Costs in Appeal Proceedings

Currently, the fees for appeal proceedings by far do not cover the costs for the EPO. Thus, on April 1, 2018, the appeal fee is increased to 2,255.00 EUR. The appeal fee remains unchanged at 1,880.00 EUR for small and medium enterprises (SMEs), natural persons or non-profit organizations, and institutions of higher education or public research institutions.

/wp-content/uploads/2022/04/boehmert_logo.svg 0 0 Petra Hettenkofer /wp-content/uploads/2022/04/boehmert_logo.svg Petra Hettenkofer2018-03-15 00:00:002018-03-15 00:00:00Need for action due to Changes to Official Fees at the EPO on April 1, 2018?

WTR1000: Excellent ratings for BOEHMERT & BOEHMERT secure it 1st place

14. March 2018/in News

‘WTR 1000 – The World’s Leading Trademark Professionals 2018’ gives top marks for a total of seven lawyers at BOEHMERT & BOEHMERT.

As regards the law firm itself, it says the following: “The impressive law firm Kanzlei BOEHMERT & BOEHMERT stands at the summit in terms of Intellectual Property.” BOEHMERT & BOEHMERT  is praised as a very well organised company which provides an extremely high level of service and always reacts quickly and reliably. For these reasons, the firm is ranked in 1st place and thus in 2018 too continues to head up the “Gold Level”.

Peter Gross, Dr. Volker Schmitz-Fohrmann, Dr. Florian Schwab und Dr. Ludwig Kouker are each given individual mention; their work is praised as follows:

Peter Gross has inspiring experience and expertise in leading companies from the creation of their first trade mark rights to the conclusion of lucrative contracts. His colleague Dr. Volker Schmitz-Fohrmann combines “enormous theoretical knowledge” with a pragmatic approach. Dr. Florian Schwab is especially convincing as counsel in complicated objection proceedings before the EUIPO and DPMA.

Dr. Ludwig Kouker stands out for his negotiating skill, is a specialist in extra-judicial settlements and has comprehensive knowledge of competition law.

WTR 1000 each year lists the leading law firms and personalities in trade mark law in 70 countries.

The detailed entries can be found here.

/wp-content/uploads/2022/04/boehmert_logo.svg 0 0 Petra Hettenkofer /wp-content/uploads/2022/04/boehmert_logo.svg Petra Hettenkofer2018-03-14 00:00:002018-03-14 00:00:00WTR1000: Excellent ratings for BOEHMERT & BOEHMERT secure it 1st place

Working Group Patent Courts in Germany – Prof. Dr. Heinz Goddar is founding member

8. March 2018/in News

The association, founded in 2017 and spearheaded by a high-calibre board, focuses on the development of patent law practice in Germany, and analyses it analyses ist from various perspectives.

To this end, an English-language database will be constructed which publishes key patent law decisions of the Federal Supreme Court.

Also, a discussions platform is to be created for discussion of German patent law practice where this and decisions in other jurisdictions can be contrasted with the aim of opening up the jurisprudence of German courts to international discussion.

The association’s website can be found here.

/wp-content/uploads/2022/04/boehmert_logo.svg 0 0 Petra Hettenkofer /wp-content/uploads/2022/04/boehmert_logo.svg Petra Hettenkofer2018-03-08 00:00:002018-03-08 00:00:00Working Group Patent Courts in Germany – Prof. Dr. Heinz Goddar is founding member

MIPLC Alumni Conference on 24.02.2018 in Munich

16. February 2018/in News

Under the title “The World of IP: Caught Between Globalism and Nationalism”, various experts will meet for the MIPLC Alumni Conference in the Literaturhaus Munich on 24 February 2018.

Prof. Dr. Heinz Goddar will host the first part of the programme entitled  “Old Issues Revisited: IP and Trade in Pharmaceuticals“.

The detailed programme as well as further information on the conference can be found here.

/wp-content/uploads/2022/04/boehmert_logo.svg 0 0 Petra Hettenkofer /wp-content/uploads/2022/04/boehmert_logo.svg Petra Hettenkofer2018-02-16 00:00:002018-02-16 00:00:00MIPLC Alumni Conference on 24.02.2018 in Munich

Protection of 3D marks – Dr. Florian Schwab explains current confectionery case

14. February 2018/in News

Commenting on the online portal of the World Trademark Review, solicitor Dr. Florian Schwab explains two recent decisions of the Federal Supreme Court on the protection of 3D marks in the case of the square packaging used by Ritter Sport chocolate and Dextro Energy glucose.

The Federal Supreme Court reversed the restrictive approach applied by the Federal Patent Court and confirmed the liberal approach to patenting three-dimensional brands. Corresponding decisions with reasoning are still awaited. The Federal Supreme Court has up to now only released press statements.

Read the entire article here.

This article was published on 05.01.2018 in WTR Daily (component of World Trademark Review).

/wp-content/uploads/2022/04/boehmert_logo.svg 0 0 Petra Hettenkofer /wp-content/uploads/2022/04/boehmert_logo.svg Petra Hettenkofer2018-02-14 00:00:002018-02-14 00:00:00Protection of 3D marks – Dr. Florian Schwab explains current confectionery case

Clinical Innovation Conference, Washington, D.C., February 8-9, 2018.

8. February 2018/in News

On February 8-9, 2018, experts will meet in Georgetown Law Center, Washington, D.C. to discuss ‘Fair and Effective Incentives for New Uses of Established Drugs’

Among other aspects, panel member Dr. Ute Kilger will talk on the subject of ‘Examples of Success – The Lyrica Story in Denmark’ and explain the legal situation in Germany.

Dr. Karl-Heinz Metten will take up the role of moderator, leading the Judges’ Panel.

Further information about the conference is available here.

/wp-content/uploads/2022/04/boehmert_logo.svg 0 0 Petra Hettenkofer /wp-content/uploads/2022/04/boehmert_logo.svg Petra Hettenkofer2018-02-08 00:00:002018-02-08 00:00:00Clinical Innovation Conference, Washington, D.C., February 8-9, 2018.

Certificates of Supplementary Protection now also in Canada

25. January 2018/in News

Supplementary Protection Certificates (SPC) play a major role alongside patents for the pharmaceutical and biotech industries, as they can provide protection for approved medicines for up to a maximum of five more years after a basic patent expires in Europe. As a result of the CETA agreement between Canada and the European Union, it is now possible for patent applicants to apply for supplementary protection certificates in Canada as well.

As a consequence of the implementation of the Comprehensive Economic and Trade Agreement (CETA) between Canada and the European Union, Canada has introduced a new and independent intellectual property right, i.e. the so-called Certificate of Supplementary Protection (CSP), which may extend the term of protection by a maximum of two years, whereas the maximum supplementary term of protection in Europe is five years. 

CSPs are available for patents comprising a claim covering a medicinal ingredient or combination of medicinal ingredients, or the use of the approved medicinal ingredient or combination of ingredients, in a drug for which a Notice of Compliance (NOC) has issued. 

CSPs may be granted on the basis of patents on pharmaceuticals, biologics and veterinary drugs, provided, of course, that said drug has been approved by the respective authorities in Canada (i.e. Health Canada). 

The CSP application must be filed before the expiry of 120 days, which begins on the day of the grant of the NOC subsequent to the regulatory approval procedure for the drug or the day of the patent grant, if the patent is granted after NOC grant. This deadline cannot be extended. 

It is mandatory that the medicinal ingredient or combination of ingredients has not been previously approved in Canada. The Canadian regulatory submission must have been filed within 12 months of a related regulatory filing in the European Union or any member countries thereof, the United States, Australia, Switzerland or Japan to be eligible for a CSP. The 12-month period may be extended to 24 months if the application for a CSP was submitted before 21 September 2018. 

The option provided by the new intellectual property right is particularly important for pharmaceutical or biomedical innovators.  It is generally estimated that the development of new drugs costs at least several hundred million US dollars. Marketed drugs protected by a patent tend to have an increasingly higher value by the end of the conventional patent term of 20 years. The possibility of obtaining an extension of protection of two years by the CSP may substantially increase the return of investment that was necessary for the development of a medication.

Furthermore, in Canada, similar to the Orange Book in the United States of America, there is the possibility of having patents registered in a patent register free of charge. Such patents must have at least one claim to a medical ingredient, formulation, dosage form, or the use of a medicinal ingredient of a drug for which a Notice of Compliance has been issued or for which a NOC procedure is pending. A patent list (Form IV) must be submitted to Health Canada in order to list the corresponding patent in the Patent Register. The Form IV letter must be filed within a non-extendable period of only 30 days after the grant of the patent.

In particular, the information on the filed patents in the Patent Register represents a hurdle for generic manufacturers and may delay the market entry of competing products.

Summary

Given the very tight deadlines for applying for CSPs or the submission of granted patents for listing in the Patent Register, patent applicants in Canada who have been granted marketing authorization or have applied for a marketing authorization should be very careful to make such requests in a timely manner.

Dr. Lüder Behrens
European Patent and Trade Mark Attorney, Berlin

/wp-content/uploads/2022/04/boehmert_logo.svg 0 0 Petra Hettenkofer /wp-content/uploads/2022/04/boehmert_logo.svg Petra Hettenkofer2018-01-25 00:00:002018-01-25 00:00:00Certificates of Supplementary Protection now also in Canada
Page 10 of 16«‹89101112›»

Latest posts

  • Scales of justice representing the Unified Patent Court (UPC) and current developments in European patent litigation
    Court of Appeal extends jurisdiction of the Central Division for infringement actions29. July 2026 - 13:43
  • Hamburg waterfront at sunset with the Elbphilharmonie
    Meet us at The Port of Hamburg by Night on October 8, 2026!28. July 2026 - 9:30
  • Portraits of Minsun Song and Dr. Fabian Schmidt to announce that they have passed the EQE exam.
    Minsun Song and Dr. Fabian Schmidt pass the European Qualifying Examination23. July 2026 - 10:56

Categories

Archive

Menu

  • Firm
  • Our Practice
  • Career
  • News & Knowledge
  • LinkedIn
  • FIND EXPERTS

Informations

  • Press
  • Contact
  • Legal notice
  • Data Protection
  • General Terms and Conditions
  • Subscription B&B Bulletin
  • Contact

Legal Areas

  • Employee Inventions
  • Data Protection
  • Designs
  • Domains
  • Information Technology
  • Anti-Trust
  • Licensing
  • Trade Marks
  • Patent Valuation
  • Patents & Utility Models
  • Patent Litigation
  • Product Piracy
  • Copyright
  • Unfair Competition

© Copyright 2026– BOEHMERT & BOEHMERT

Scroll to top Scroll to top Scroll to top